GE's non-invasive SMS-EIT prototype system provides higher signal-to-noise ratio and greater sensitivity to continuously image pulmonary perfusion and ventilation.

Low-cost manufacturing platform for disposable, hospital-grade multi-parameter clinical monitoring devices.

Hydration status monitoring based on wearable sweat-based sensing

Developing cutting edge technologies in machine architectures, energy sources, sensing and controls for step-change in build size and speed, while assuring part quality.

Real-time, sub-micron, 3D visualizations of microstructure to create and validate damage accumulation models.

Addressing the needs in this emerging immunotherapy market with the design and development of a modular platform for commercial scale manufacturing.

We advance the state of the art in multiscale durability models for ceramic matrix composites (CMCs).

Combining genetically variable peptides and DNA profiling to enable single contributor identification via proteomics for forensic applications.

This project aims to use quantitative-ultrasound (QUS) methods for detecting metastases in lymph nodes in a broad range of cancer types.

Cancer cell biology is highly complex, comprising multiple cell types in different metabolic states, and is spatially heterogeneous. Over the last 10 years, our GE Research multi-disciplinary team has developed a multiplexed imaging and cell level analytics technology that allows analysis of up to 60 protein biomarkers in every cell in a 5 um FFPE tissue section (Cell DIVE™).